{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1500, 
        1506
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1029, 
        1043
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1484, 
        1498
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2155, 
        2178
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        945, 
        972
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        466, 
        495
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2078, 
        2113
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        900, 
        926
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1045, 
        1052
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1067, 
        1068
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        974, 
        989
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1019, 
        1028
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1230, 
        1247
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170919125843||ORU^R01^ORU_R01|201709191258430001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-010704^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170804000000|||||||20170805000000|&Prostate, TUR|1770650145^^^^^^MD^^CMS^D^^^NPI||||||20170809000000|||F||||||C61^Malignant neoplasm of prostate^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient's name is \"\" identified by requisition and specimen container label. Received in formalin in 2 containers each labeled with the patient's name and \"prostate chips\" is a 119 g, 9 x 8 x up to 4 cm loose aggregate of tan focally rubbery pieces of tissue all of which are received within 2 accompanying intact suction filter traps. Representative pieces are submitted in cassettes 1A-1M. (RH)\n\n\nPath report.site of origin\n\nProstate chips\n\n\nPath report.final diagnosis\n\nProstate tissue (transurethral resection):   Prostatic adenocarcinoma, Gleason's pattern 5+4=9.   Tumor involves 30% of the submitted tissue.   No periprostatic fat invasion identified.   No lymphovascular invasion seen.   Perineural invasion is present.  CANCER CHECKLIST: PROSTATE GLAND: Transurethral Prostatic Resection (TUR), Enucleation Specimen (Subtotal Prostatectomy) 2.002.001.1000043 SPECIMEN  Procedure: Transurethral prostatic resection Specimen Size  Weight (g): 116grams TUMOR  Histologic Type: Adenocarcinoma (acinar, not otherwise specified) Histologic Grade  Gleason Pattern: Gleason pattern (specify)  Primary (predominant) Pattern: Grade 5  Secondary (worst remaining) Pattern: Grade 4  Total Gleason Score: 9,, Grade group 5 EXTENT  Tumor Quantitation: TUR Specimens  Proportion (percentage) of Prostatic Tissue Involved by Tumor: 30%  Periprostatic Fat Invasion: Not identified  Seminal Vesicle Invasion: Not identified ACCESSORY FINDINGS  Lymph-Vascular Invasion: Not identified  Perineural Invasion: Present ADDITIONAL NON-TUMOR  Additional Pathologic Findings: None identified\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Enlarged prostate with lower urinary tract symptoms (N40.1)\n\n\n"
}